[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"leadSponsorName\":\"Ludwig Boltzmann Institute for Arthritis and Rehabilitation\",\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:":47},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,1,0,[8],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":14,"acronym":15,"eligibilityCriteria":16,"healthyVolunteers":11,"sex":17,"minAge":18,"maxAge":19,"enrollmentInfo":20,"targetDuration":4,"studyType":23,"phases":24,"briefSummary":26,"conditions":27,"keywords":32,"overallStatus":35,"whyStopped":4,"lastUpdateSubmitDate":36,"lastUpdatePostDateStruct":37,"startDateStruct":40,"completionDateStruct":42,"leadSponsor":44,"locationsCount":5},"100633620","the-potential-of-robotic-assisted-gait-training-in-a-rehabilitation-setting-100633620",false,"NCT07529054","The Potential of Robotic-Assisted Gait Training in a Rehabilitation Setting","The Potential of Robotic-Assisted Gait Training in a Rehabilitation Settin","RAGT_RGB","Inclusion Criteria:\n\n* Diagnosis of stroke (ischemic or hemorrhagic) ≥ 3 months\n* Age ≥ 18a and ≤ 80a\n* 6MWT ≤ 200m\n* Barthel Index ≤ 95\n* Mini Mental State Exam (MMSE) ≥ 24\n* FAC: ≤ 4\n* BBS): ≤49\n* Modified Ashworth Scale (MAS): 0-3 for the lower extremity\n\nExclusion Criteria:\n\n* The presence of any comorbidity or disability other than stroke that would preclude gait training\n* Any uncontrolled health condition for which exercise is contraindicated","ALL","18 Years","80 Years",{"count":21,"type":22},40,"ESTIMATED","INTERVENTIONAL",[25],"NA","Robotic-assisted gait training (RAGT) devices, such as the Lokomat®, are commonly used to support gait rehabilitation by enabling repetitive, task-specific walking movements. The functional proprioceptive stimulation (FPS) device Vibramoov® represents a novel technology designed to stimulate proprioceptors at the muscle-tendon junction through targeted vibratory stimuli, thereby activating sensorimotor centers in the brain and potentially facilitating movement execution.\n\nThe aim of this randomized controlled trial is to investigate whether Lokomat® training combined with Vibramoov® leads to greater improvements in qualitative and quantitative gait parameters in stroke patients compared with Lokomat® training alone. The study will be conducted at the Gröbming Rehabilitation Center and will include patients undergoing a four-week neurological inpatient rehabilitation program. Participants will be randomly assigned to an intervention group (Lokomat® + Vibramoov®) or a control group (Lokomat® only), with 20 patients per group.\n\nPrimary outcomes include the 6-Minute Walk Test (6MWT) and spatiotemporal gait parameters. Additional assessments include functional scores, patient-reported outcome measures, and blood biomarkers. Statistical analyses will be performed depending on data distribution. A follow-up assessment evaluating EQ-5D and PHQ-4 will be conducted six months after completion of the rehabilitation program.",[28,29,30,31],"Stroke","Robotic Assisted Gait Training","Vibration Therapy","Gait Biomechanics",[29,33,34],"Functional Proprioceptive Stimulation","Gait Parameter","RECRUITING","2026-04-07",{"date":38,"type":39},"2026-04-14","ACTUAL",{"date":41,"type":39},"2026-01-05",{"date":43,"type":22},"2027-12",{"name":45,"class":46},"Ludwig Boltzmann Institute for Arthritis and Rehabilitation","NETWORK",""]